Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonists as new psychoactive substances: Origins In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 165-190. 906 kB. https://doi.org/10.1007/164_2018_143 #26
Banister, SD; Kumar, KK; Kumar, V; Kobilka, BK; Malhotra, SV. Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain Med. Chem. Commun., 22 May 2019, 10 (5), 647–659. 810 kB. https://doi.org/10.1039/C8MD00595H #11
Eissenstat, MA; Bell, MR; D’Ambra, TE; Alexander, EJ; Daum, SJ; Ackerman, JH; Gruett, MD; Kumar, V; Estep, KG. Aminoalkylindoles: Structure-activity relationships of novel cannabinoid mimetics J. Med. Chem., 1 Aug 1995, 38 (16), 3094–3105. 3.0 MB. https://doi.org/10.1021/jm00016a013 #84 NMR,IR